Copyright Reports & Markets. All rights reserved.

Global Biosimilar Testing Service Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Biosimilar Testing Service Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Pharmacokinetic Assay
    • 1.4.3 Tiered Immunogenicity Testing
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Biosimilar Testing Service Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Pharmaceutical Companies
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Biosimilar Testing Service Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Biosimilar Testing Service Industry
      • 1.6.1.1 Biosimilar Testing Service Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Biosimilar Testing Service Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Biosimilar Testing Service Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Biosimilar Testing Service Market Perspective (2015-2026)
  • 2.2 Biosimilar Testing Service Growth Trends by Regions
    • 2.2.1 Biosimilar Testing Service Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biosimilar Testing Service Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biosimilar Testing Service Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Biosimilar Testing Service Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Biosimilar Testing Service Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Biosimilar Testing Service Players by Market Size
    • 3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2015-2020)
    • 3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Biosimilar Testing Service Market Concentration Ratio
    • 3.2.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2019
  • 3.3 Biosimilar Testing Service Key Players Head office and Area Served
  • 3.4 Key Players Biosimilar Testing Service Product Solution and Service
  • 3.5 Date of Enter into Biosimilar Testing Service Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Biosimilar Testing Service Historic Market Size by Type (2015-2020)
  • 4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2021-2026)

5 Biosimilar Testing Service Breakdown Data by Application (2015-2026)

  • 5.1 Global Biosimilar Testing Service Market Size by Application (2015-2020)
  • 5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biosimilar Testing Service Market Size (2015-2020)
  • 6.2 Biosimilar Testing Service Key Players in North America (2019-2020)
  • 6.3 North America Biosimilar Testing Service Market Size by Type (2015-2020)
  • 6.4 North America Biosimilar Testing Service Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Biosimilar Testing Service Market Size (2015-2020)
  • 7.2 Biosimilar Testing Service Key Players in Europe (2019-2020)
  • 7.3 Europe Biosimilar Testing Service Market Size by Type (2015-2020)
  • 7.4 Europe Biosimilar Testing Service Market Size by Application (2015-2020)

8 China

  • 8.1 China Biosimilar Testing Service Market Size (2015-2020)
  • 8.2 Biosimilar Testing Service Key Players in China (2019-2020)
  • 8.3 China Biosimilar Testing Service Market Size by Type (2015-2020)
  • 8.4 China Biosimilar Testing Service Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Biosimilar Testing Service Market Size (2015-2020)
  • 9.2 Biosimilar Testing Service Key Players in Japan (2019-2020)
  • 9.3 Japan Biosimilar Testing Service Market Size by Type (2015-2020)
  • 9.4 Japan Biosimilar Testing Service Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Biosimilar Testing Service Market Size (2015-2020)
  • 10.2 Biosimilar Testing Service Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Biosimilar Testing Service Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Biosimilar Testing Service Market Size by Application (2015-2020)

11 India

  • 11.1 India Biosimilar Testing Service Market Size (2015-2020)
  • 11.2 Biosimilar Testing Service Key Players in India (2019-2020)
  • 11.3 India Biosimilar Testing Service Market Size by Type (2015-2020)
  • 11.4 India Biosimilar Testing Service Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Biosimilar Testing Service Market Size (2015-2020)
  • 12.2 Biosimilar Testing Service Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Biosimilar Testing Service Market Size by Type (2015-2020)
  • 12.4 Central & South America Biosimilar Testing Service Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Charles River Laboratories International
    • 13.1.1 Charles River Laboratories International Company Details
    • 13.1.2 Charles River Laboratories International Business Overview and Its Total Revenue
    • 13.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction
    • 13.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2015-2020))
    • 13.1.5 Charles River Laboratories International Recent Development
  • 13.2 Merck
    • 13.2.1 Merck Company Details
    • 13.2.2 Merck Business Overview and Its Total Revenue
    • 13.2.3 Merck Biosimilar Testing Service Introduction
    • 13.2.4 Merck Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.2.5 Merck Recent Development
  • 13.3 PPD
    • 13.3.1 PPD Company Details
    • 13.3.2 PPD Business Overview and Its Total Revenue
    • 13.3.3 PPD Biosimilar Testing Service Introduction
    • 13.3.4 PPD Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.3.5 PPD Recent Development
  • 13.4 LAB Holdings
    • 13.4.1 LAB Holdings Company Details
    • 13.4.2 LAB Holdings Business Overview and Its Total Revenue
    • 13.4.3 LAB Holdings Biosimilar Testing Service Introduction
    • 13.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.4.5 LAB Holdings Recent Development
  • 13.5 Eurofins Scientific
    • 13.5.1 Eurofins Scientific Company Details
    • 13.5.2 Eurofins Scientific Business Overview and Its Total Revenue
    • 13.5.3 Eurofins Scientific Biosimilar Testing Service Introduction
    • 13.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.5.5 Eurofins Scientific Recent Development
  • 13.6 Intertek
    • 13.6.1 Intertek Company Details
    • 13.6.2 Intertek Business Overview and Its Total Revenue
    • 13.6.3 Intertek Biosimilar Testing Service Introduction
    • 13.6.4 Intertek Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.6.5 Intertek Recent Development
  • 13.7 SGS
    • 13.7.1 SGS Company Details
    • 13.7.2 SGS Business Overview and Its Total Revenue
    • 13.7.3 SGS Biosimilar Testing Service Introduction
    • 13.7.4 SGS Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.7.5 SGS Recent Development
  • 13.8 Profacgen
    • 13.8.1 Profacgen Company Details
    • 13.8.2 Profacgen Business Overview and Its Total Revenue
    • 13.8.3 Profacgen Biosimilar Testing Service Introduction
    • 13.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.8.5 Profacgen Recent Development
  • 13.9 Antibody Analytics
    • 13.9.1 Antibody Analytics Company Details
    • 13.9.2 Antibody Analytics Business Overview and Its Total Revenue
    • 13.9.3 Antibody Analytics Biosimilar Testing Service Introduction
    • 13.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.9.5 Antibody Analytics Recent Development
  • 13.10 Kymos Pharma Services
    • 13.10.1 Kymos Pharma Services Company Details
    • 13.10.2 Kymos Pharma Services Business Overview and Its Total Revenue
    • 13.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction
    • 13.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2015-2020)
    • 13.10.5 Kymos Pharma Services Recent Development
  • 13.11 Medicilon
    • 10.11.1 Medicilon Company Details
    • 10.11.2 Medicilon Business Overview and Its Total Revenue
    • 10.11.3 Medicilon Biosimilar Testing Service Introduction
    • 10.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2015-2020)
    • 10.11.5 Medicilon Recent Development
  • 13.12 Pacific BioLabs
    • 10.12.1 Pacific BioLabs Company Details
    • 10.12.2 Pacific BioLabs Business Overview and Its Total Revenue
    • 10.12.3 Pacific BioLabs Biosimilar Testing Service Introduction
    • 10.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2015-2020)
    • 10.12.5 Pacific BioLabs Recent Development
  • 13.13 Sartorius
    • 10.13.1 Sartorius Company Details
    • 10.13.2 Sartorius Business Overview and Its Total Revenue
    • 10.13.3 Sartorius Biosimilar Testing Service Introduction
    • 10.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2015-2020)
    • 10.13.5 Sartorius Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Biosimilar Testing Service status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimilar Testing Service development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Charles River Laboratories International
    Merck
    PPD
    LAB Holdings
    Eurofins Scientific
    Intertek
    SGS
    Profacgen
    Antibody Analytics
    Kymos Pharma Services
    Medicilon
    Pacific BioLabs
    Sartorius

    Market segment by Type, the product can be split into
    Pharmacokinetic Assay
    Tiered Immunogenicity Testing
    Others
    Market segment by Application, split into
    Hospitals
    Pharmaceutical Companies
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Biosimilar Testing Service status, future forecast, growth opportunity, key market and key players.
    To present the Biosimilar Testing Service development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Biosimilar Testing Service are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now